Indeed, lower ADAMS-13 levels have been described in COVID-19 patients where an elevated vWF:ADAMST-13 ratio strongly correlates with the severity of the disease and associates with endotheliopathy and immune dysfunction in long COVID syndrome [52–54]. This evidence concerns the gene VWF and COVID-19.